Literature DB >> 2180927

Equilibrium denaturation of human growth hormone and its cysteine-modified forms.

D N Brems1, P L Brown, G W Becker.   

Abstract

The equilibrium denaturation of human growth hormone (hGH) derived from heterologous gene expression in Escherichia coli was studied. Denaturation was measured by ultraviolet absorbance, intrinsic fluorescence, far ultraviolet circular dichroism, and size exclusion chromatography. The denaturation transitions obtained from each method of detection were coincident, indicating a two-state denaturation mechanism. The denaturation transitions were independent of the concentration of protein. The Gibbs free energy of unfolding is 14.5 +/- 1 kcal/mol. Human growth hormone contains two disulfide bridges between residues 53-165 (large loop) and 182-189 (small loop). The small loop was selectively reduced and cysteines alkylated with iodoacetic acid or iodoacetamide. The tetra-S-carbamidomethylated and tetra-S-carboxymethylated derivatives were also prepared. All S-alkylated hGH forms were indistinguishable from the native conformations in the absence of denaturant by far ultraviolet circular dichroism. The circular dichroism-detected equilibrium denaturation of each derivative was determined and the Gibbs free energy of unfolding of the tetra-S-modified forms was 5.3 +/- 0.5 kcal/mol and of the di-S-alkylated derivatives was 11.2 +/- 0.8 kcal/mol. These results for hGH are different than previously obtained results for bovine, ovine, and rat growth hormones. Stable equilibrium intermediates have been identified for these non-human species of growth hormone. The stable intermediates observed in the denaturation of reduced, alkylated hGH or nonhunam growth hormones are similar and characterized as compact, helical, lacking native-like tertiary structure, and having a tendency to aggregate. The apparent absence of intermediates in the folding of oxidized hGH is due to the relative instability of intermediates compared with their native structures. The hGH conformation is at least 5 kcal/mol more stable than the growth hormones from other species. Reduction and alkylation of the disulfide bridges of hGH diminish the stability differences between the native and intermediate states, such that the denaturation behavior is similar to the nonhuman growth hormones with well-populated intermediates. Most proteins do not demonstrate equilibrium folding intermediates presumably because intermediates are only marginally stable in conditions that disrupt the native state. The folding results with hGH and alkylated hGH substantiate this.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Enthalpic and entropic contributions mediate the role of disulfide bonds on the conformational stability of interleukin-4.

Authors:  Daniela C Vaz; J Rui Rodrigues; Walter Sebald; Christopher M Dobson; Rui M M Brito
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

Review 2.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Comparison of guanidine hydrochloride (GdnHCl) and urea denaturation on inactivation and unfolding of human placental cystatin (HPC).

Authors:  Fouzia Rashid; Sandeep Sharma; Bilqees Bano
Journal:  Protein J       Date:  2005-07       Impact factor: 2.371

4.  Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

Authors:  Muppalla Sukumar; Sacha M Storms; Michael R De Felippis
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

5.  Optimization and applications of CDAP labeling for the assignment of cysteines.

Authors:  Gary D Pipes; Andrew A Kosky; Jeffrey Abel; Yu Zhang; Michael J Treuheit; Gerd R Kleemann
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

6.  Proteolysis of human growth hormone by rat thyroid gland in vitro: application of electrospray mass spectrometry and N-terminal sequencing to elucidate a metabolic pathway.

Authors:  V J Wroblewski; R E Kaiser; G W Becker
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

7.  Thermodynamic characterization of an intermediate state of human growth hormone.

Authors:  I Gomez-Orellana; B Variano; J Miura-Fraboni; S Milstein; D R Paton
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

8.  Denaturation and Aggregation of Interferon-τ in Aqueous Solution.

Authors:  Ryan R Manning; Glenn A Wilson; Ryan E Holcomb; Nathaniel J Zbacnik; Auria A Tellechea; Chelsey L Gilley-Dunn; Ryan J Krammes; Nathan S Krammes; Gabriel J Evans; Charles S Henry; Mark Cornell Manning; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2018-05-09       Impact factor: 4.200

9.  The unique cysteine knot regulates the pleotropic hormone leptin.

Authors:  Ellinor Haglund; Joanna I Sułkowska; Zhao He; Gen-Sheng Feng; Patricia A Jennings; José N Onuchic
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

10.  Pierced Lasso Bundles are a new class of knot-like motifs.

Authors:  Ellinor Haglund; Joanna I Sulkowska; Jeffrey K Noel; Heiko Lammert; José N Onuchic; Patricia A Jennings
Journal:  PLoS Comput Biol       Date:  2014-06-19       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.